Berenberg Bank reissued their buy rating on shares of Gerresheimer (OTCMKTS:GRRMF) in a report published on Wednesday morning, The Fly reports.
GRRMF stock opened at $113.00 on Wednesday. The business has a 50 day simple moving average of $85.80 and a 200-day simple moving average of $78.61. Gerresheimer has a 1 year low of $71.41 and a 1 year high of $113.00.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Recommended Story: Price-Sales Ratio
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.